These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 25399714)

  • 41. ADME pharmacogenetics: current practices and future outlook.
    Grossman I
    Expert Opin Drug Metab Toxicol; 2009 May; 5(5):449-62. PubMed ID: 19416082
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Update information for physicians on laboratory tests: recent progress in clinical laboratory testing. Topics: I. Generalities; 3. A commentary on guidelines for gene-based testing].
    Miyachi H
    Nihon Naika Gakkai Zasshi; 2011 Nov; 100(11):3182-92. PubMed ID: 22250409
    [No Abstract]   [Full Text] [Related]  

  • 43. Removing barriers to a clinical pharmacogenetics service.
    Newman W; Payne K
    Per Med; 2008 Sep; 5(5):471-480. PubMed ID: 29783451
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Utility of Pharmacogenetics Testing in Psychiatric Populations.
    Jürgens G
    J Pers Med; 2021 Dec; 11(12):. PubMed ID: 34945734
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A call for accurate pharmacogenetic labeling: telling it like it is.
    Burke W; Thummel K
    JAMA Intern Med; 2014 Dec; 174(12):1945-6. PubMed ID: 25317574
    [No Abstract]   [Full Text] [Related]  

  • 46. Clarity Also Needed for Direct-to-Consumer Pharmacogenetic Tests.
    Patel JN; McLeod HL
    J Clin Oncol; 2020 Jan; 38(3):283-284. PubMed ID: 31751161
    [No Abstract]   [Full Text] [Related]  

  • 47. Potential use of auxiliary labels to promote patient awareness of pharmacogenetic testing.
    Haga SB; Moaddeb J
    Pharmacogenomics; 2015; 16(4):299-301. PubMed ID: 25823778
    [No Abstract]   [Full Text] [Related]  

  • 48. The use of human liver banks in pharmacogenetic research.
    von Bahr C; Guengerich FP; Movin G; Nordin C
    Psychopharmacol Ser; 1989; 7():163-71. PubMed ID: 2687854
    [No Abstract]   [Full Text] [Related]  

  • 49. [Pharmacogenetic studies assessment in clinical research: Four issues, four opinions].
    Cabrera L; Abad-Santos F; Ayuso C; Dal-Ré R
    Med Clin (Barc); 2010 Sep; 135(7):326-9. PubMed ID: 20800163
    [No Abstract]   [Full Text] [Related]  

  • 50. Delivering pharmacogenetic testing to the masses: an achievable goal?
    Haga SB
    Pharmacogenomics; 2014 Jan; 15(1):1-4. PubMed ID: 24329184
    [No Abstract]   [Full Text] [Related]  

  • 51. Clinical use of pre-emptive pharmacogenetic programmes.
    Peñas-LLedó E; LLerena A
    Lancet; 2023 Feb; 401(10374):320-321. PubMed ID: 36739126
    [No Abstract]   [Full Text] [Related]  

  • 52. Corrigendum to: "Pharmacogenetic testing in psychiatry: Perspective on clinical utility" [Asian J. Psychiatry 86 (2023) 103674].
    Adiukwu F; Adesokun O; Essien E; Yalcin N; Ransing R; Nagendrappa S; Jatchavala C; Omotoso ABO; Nawaz FA; Khan N
    Asian J Psychiatr; 2023 Nov; 89():103753. PubMed ID: 37647786
    [No Abstract]   [Full Text] [Related]  

  • 53. Compensation in clinical research: The debate continues.
    Pandya M; Desai C
    Perspect Clin Res; 2013 Jan; 4(1):70-4. PubMed ID: 23533986
    [No Abstract]   [Full Text] [Related]  

  • 54. Pilot study of pharmacist-assisted delivery of pharmacogenetic testing in a primary care setting.
    Haga SB; LaPointe NM; Cho A; Reed SD; Mills R; Moaddeb J; Ginsburg GS
    Pharmacogenomics; 2014 Sep; 15(13):1677-86. PubMed ID: 25410893
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pilot study: incorporation of pharmacogenetic testing in medication therapy management services.
    Haga SB; Allen LaPointe NM; Moaddeb J; Mills R; Patel M; Kraus WE
    Pharmacogenomics; 2014 Nov; 15(14):1729-1737. PubMed ID: 25493566
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cost-effectiveness of one-time genetic testing to minimize lifetime adverse drug reactions.
    Alagoz O; Durham D; Kasirajan K
    Pharmacogenomics J; 2016 Apr; 16(2):129-36. PubMed ID: 25987241
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Meta-analysis of efficacy and safety of genotype-guided pharmacogenetic dosing of warfarin.
    Xu H; Xie X; Wang B; Chen Y; Meng T; Ma S; Wang F
    Int J Cardiol; 2014 Dec; 177(2):654-7. PubMed ID: 25449474
    [No Abstract]   [Full Text] [Related]  

  • 58. The potential utility of pharmacogenetic testing in psychiatry.
    Gardner KR; Brennan FX; Scott R; Lombard J
    Psychiatry J; 2014; 2014():730956. PubMed ID: 25587529
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An index of barriers for the implementation of personalised medicine and pharmacogenomics in Europe.
    Horgan D; Jansen M; Leyens L; Lal JA; Sudbrak R; Hackenitz E; Bußhoff U; Ballensiefen W; Brand A
    Public Health Genomics; 2014; 17(5-6):287-98. PubMed ID: 25401385
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of contemporary genetics in cardiovascular diagnosis.
    George AL
    Circulation; 2014 Nov; 130(22):1971-80. PubMed ID: 25421045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.